post

Myeloma UK rewards clinical excellence

Myeloma UK news // 30th January 2018

Hospitals around the country have been presented with the Myeloma UK Clinical Service Excellence Programme Award (Myeloma UK CSEP), in recognition of their commitment to providing outstanding treatment and care to their patients and their families.

The award programme was established in 2015 to recognise when superior care is given to myeloma patients, share best practice initiatives and to benchmark optimum standards in myeloma treatment. Participation brings about positive change by helping frontline staff define, drive and share service improvements.

 

 

Dr Kamaraj Karunanithi, Consultant Haematologist at the Royal Stoke University Hospital and who leads the myeloma service in University Hospitals of North Midlands (UHNM), said: “Myeloma is often difficult to diagnose, as symptoms may be non-specific. In the last 10 years, with improvements in treatment and care, survival rates are increasing faster than most other cancers. Despite this, the diagnosis is often delayed, and most patients ultimately die from their myeloma”.

“The work we are doing here at UHNM ensures local myeloma patients can access top-quality care and ground-breaking research. I am delighted we have been given this award.”

 

The work we are doing here at UHNM ensures local myeloma patients can access top-quality care and ground-breaking research. I am delighted we have been given this award.

Dr Kamaraj Karunanithi, Consultant Haematologist at the Royal Stoke University Hospital
Ely Taylor (Myeloma UK) with Julie Watson (Myeloma CNS), Colchester General Hospital

Programme standards are evidence-based and backed up by experienced healthcare professionals (HCPs) who have led service change and understand what constitutes the best treatment and care in myeloma. Patients play a pivotal role in the CSEP process. For hospitals to obtain the award, patients need to complete a patient experience survey that asks a number of questions from diagnosis through to clinical trials. Myeloma UK then combines the patient feedback with an online self-assessment questionnaire that the hospital team completes ensuring that optimum care and treatment is delivered throughout.

Dr Alastair Whiteway from Southmead Hospital said that “the process of going through the [CSEP] self-assessment tool has been beneficial in that it gave us the opportunity to review areas of our practice that we may not have otherwise looked at.”

Suzanne Renwick, Healthcare Professional Projects Manager, Myeloma UK, said “Being presented with the Myeloma UK CSEP Award is a considerable achievement and shows that hospitals across the UK are dedicated to providing excellent treatment and care. The Myeloma UK CSEP award demonstrates the gold standard of myeloma care.”

To view participating hospitals, visit the CSEP website. For more information on how your hospital can apply please contact csep@myeloma.org.uk.